✦ LIBER ✦

Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515

✍ Scribed by Yoshida, Kimihide; Sugiura, Takahiko; Takifuji, Nobuhide; Kawahara, Masaaki; Matsui, Kaoru; Kudoh, Shinzoh; Takada, Minoru; Fukuoka, Masahiro; Ariyoshi, Yutaka; Fukuda, Haruhiko; Saijo, Nagahiro

Book ID: 119319718
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 311 KB
Volume: 58
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2007.07.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of intrapleural paclitaxe

Phase II trial of intrapleural paclitaxel injection for non-small-cell lung cancer patients with malignant pleural effusions

✍ R.-P. Perng; Y.-M. Chen; M.-F. Wu; K.-C. Chou; W.-C. Lin; J.M. Liu; J. Whang-Pen 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 764 KB

Paclitaxel plus cisplatin is as effectiv

Paclitaxel plus cisplatin is as effective as regimens containing gemcitabine in people with advanced non-small cell lung cancer: Abstracted from: Smit EF, van Meerbeeck JP, Lianes P, et al. Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group-EORTC 08975. J Clin Oncol 2003;21:3909–17.

✍ Sarah Danson 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 163 KB